|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu R, Qian M, Zhou T and Cui P: TP53
mediated miR-3647-5p prevents progression of cervical carcinoma by
targeting AGR2. Cancer Med. 8:6095–6105. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Federico C, Sun J, Muz B, Alhallak K,
Cosper PF, Muhammad N, Jeske A, Hinger A, Markovina S, Grigsby P,
et al: Localized delivery of cisplatin to cervical cancer improves
its therapeutic efficacy and ninimizes its side effect profile. Int
J Radiat Oncol Biol Phys. Nov 27–2020.(Epub ahead of print). doi:
10.1016/j.ijrobp.2020.11.052. PubMed/NCBI
|
|
4
|
Matsuoka H, Murakami R, Abiko K, Yamaguchi
K, Horie A, Hamanishi J, Baba T and Mandai M: UGT1A1 polymorphism
has a prognostic effect in patients with stage IB or II uterine
cervical cancer and one or no metastatic pelvic nodes receiving
irinotecan chemotherapy: A retrospective study. BMC Cancer.
20:7292020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu H, Luo H, Zhang W, Shen Z, Hu X and
Zhu X: Molecular mechanisms of cisplatin resistance in cervical
cancer. Drug Des Devel Ther. 10:1885–1895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng TL, Li DP, He ZF and Zhao S: miR-145
sensitizes esophageal squamous cell carcinoma to cisplatin through
directly inhibiting PI3K/AKT signaling pathway. Cancer Cell Int.
19:2502019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mesci A, Huang X, Taeb S, Jahangiri S, Kim
Y, Fokas E, Bruce J, Leong HS and Liu SK: Targeting of CCBE1 by
miR-330-3p in human breast cancer promotes metastasis. Br J Cancer.
116:1350–1357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiu Z, Li H, Wang J and Sun C: miR-146a
and miR-146b in the diagnosis and prognosis of papillary thyroid
carcinoma. Oncol Rep. 38:2735–2740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okazaki J, Tanahashi T, Sato Y, Miyoshi J,
Nakagawa T, Kimura T, Miyamoto H, Fujino Y, Nakamura F, Takehara M,
et al: MicroRNA-296-5p promotes cell invasion and drug resistance
by targeting Bcl2-related ovarian killer, leading to a poor
prognosis in pancreatic cancer. Digestion. 101:794–806. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng Y, Zou W, Hu C, Li G, Zhou S, He Y,
Ma F, Deng C and Sun L: Modulation of CASC2/miR-21/PTEN pathway
sensitizes cervical cancer to cisplatin. Arch Biochem Biophys.
623-624:20–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang WK, Akçakaya P, Gangaev A, Lee L,
Zeljic K, Hajeri P, Berglund E, Ghaderi M, Åhlén J, Bränström R, et
al: miR-125a-5p regulation increases phosphorylation of FAK that
contributes to imatinib resistance in gastrointestinal stromal
tumors. Exp Cell Res. 371:287–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi B, Ma C, Liu G and Guo Y: miR-106a
directly targets LIMK1 to inhibit proliferation and EMT of oral
carcinoma cells. Cell Mol Biol Lett. 24:12019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang H, Wang Y, Xing F, Wang J, Wang Y,
Wang H, Yang Y and Gao Z: Overexpression of LIMK1 promotes
migration ability of multidrug-resistant osteosarcoma cells. Oncol
Res. 19:501–509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Q, Jiao D, Hu H, Song J, Yan J, Wu L
and Xu LQ: Downregulation of LIMK1 level inhibits migration of lung
cancer cells and enhances sensitivity to chemotherapy drugs. Oncol
Res. 20:491–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue F, Xu Y, Song Y, Zhang W, Li R and Zhu
X: The effects of sevoflurane on the progression and cisplatinum
sensitivity of cervical cancer cells. Drug Des Devel Ther.
13:3919–3928. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao Y, Liang MR, Liu CC, Wang YN, Zeng Y,
Zhou J, Zhu HT, Wang Q, Zou Y and Zeng SY: Overexpression of P16
reversed the MDR1-mediated DDP resistance in the cervical
adenocarcinoma by activating the ERK1/2 signaling pathway. Cell
Div. 14:62019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Conte E, Bresciani E, Rizzi L, Cappellari
O, De Luca A, Torsello A and Liantonio A: Cisplatin-Induced
skeletal muscle dysfunction: Mechanisms and counteracting
therapeutic strategies. Int J Mol Sci. 21:E12422020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi SA, Kim GW, Yoo J, Han JW and Kwon SH:
HP1γ sensitizes cervical cancer cells to cisplatin through the
suppression of UBE2L3. Int J Mol Sci. 21:59762020. View Article : Google Scholar
|
|
20
|
Xu X, Jiang X, Chen L, Zhao Y, Huang Z,
Zhou H and Shi M: miR-181a promotes apoptosis and reduces cisplatin
resistance by inhibiting osteopontin in cervical cancer cells.
Cancer Biother Radiopharm. 34:559–565. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang LL and Rao W: SiRNA interfering
STAT3 enhances DDP sensitivity in cervical cancer cells. Eur Rev
Med Pharmacol Sci. 22:4098–4106. 2018.PubMed/NCBI
|
|
22
|
Xia J, Yu X, Song X, Li G, Mao X and Zhang
Y: Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin
resistance in human cervical cancer cells. Mol Med Rep. 15:488–494.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang X, Qiu J, Kang H, Wang Y and Qian J:
miR-125a-5p suppresses colorectal cancer progression by targeting
VEGFA. Cancer Manag Res. 10:5839–5853. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Zhang D, Lv J, Wang S and Zhang
Q: miR-125a-5p suppresses bladder cancer progression through
targeting FUT4. Biomed Pharmacother. 108:1039–1047. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan L, Yu MC, Gao GL, Liang HW, Zhou XY,
Zhu ZT, Zhang CY, Wang YB and Chen X: miR-125a-5p functions as a
tumour suppressor in breast cancer by downregulating BAP1. J Cell
Biochem. 119:8773–8783. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qin X, Wan Y, Wang S and Xue M:
MicroRNA-125a-5p modulates human cervical carcinoma proliferation
and migration by targeting ABL2. Drug Des Devel Ther. 10:71–79.
2015.PubMed/NCBI
|
|
27
|
Liu R, Wang M, Li E, Yang Y, Li J, Chen S,
Shen WJ, Azhar S, Guo Z and Hu Z: Dysregulation of microRNA-125a
contributes to obesity-associated insulin resistance and
dysregulates lipid metabolism in mice. Biochim Biophys Acta Mol
Cell Biol Lipids. 1865:1586402020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Y, Ma K, Yang S, Zhang X, Wang F,
Zhang X, Liu H and Fan Q: MicroRNA-125a-5p enhances the sensitivity
of esophageal squamous cell carcinoma cells to cisplatin by
suppressing the activation of the STAT3 signaling pathway. Int J
Oncol. 53:644–658. 2018.PubMed/NCBI
|
|
29
|
Su J, Zhou Y, Pan Z, Shi L, Yang J, Liao
A, Liao Q and Su Q: Downregulation of LIMK1-ADF/cofilin by DADS
inhibits the migration and invasion of colon cancer. Sci Rep.
7:456242017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen P, Zeng M, Zhao Y and Fang X:
Upregulation of Limk1 caused by microRNA-138 loss aggravates the
metastasis of ovarian cancer by activation of Limk1/cofilin
signaling. Oncol Rep. 32:2070–2076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
You T, Gao W, Wei J, Jin X, Zhao Z, Wang C
and Li Y: Overexpression of LIMK1 promotes tumor growth and
metastasis in gastric cancer. Biomed Pharmacother. 69:96–101. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wei WF, Zhou CF, Wu XG, He LN, Wu LF, Chen
XJ, Yan RM, Zhong M, Yu YH, Liang L, et al: MicroRNA-221-3p, a
TWIST2 target, promotes cervical cancer metastasis by directly
targeting THBS2. Cell Death Dis. 8:32202017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peng Y, Zhang X, Ma Q, Yan R, Qin Y, Zhao
Y, Cheng Y, Yang M, Wang Q, Feng X, et al: MiRNA-194 activates the
Wnt/β-catenin signaling pathway in gastric cancer by targeting the
negative Wnt regulator, SUFU. Cancer Lett. 385:117–127. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu S, Zheng Q, Wu H, Wang C, Liu T and
Zhou W: miR-532 promoted gastric cancer migration and invasion by
targeting NKD1. Life Sci. 177:15–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng C, Ma F, Hu C, Ma JA, Wang J, Zhang
Y, Wu F, Hou T, Jiang S, Wang Y, et al: SOX9/miR-130a/CTR1 axis
modulates DDP-resistance of cervical cancer cell. Cell Cycle.
17:448–458. 2018. View Article : Google Scholar : PubMed/NCBI
|
